Stem Cell Therapy for Crohn’s Disease Approved in Europe
The European Commission has approved Alofisel, previously known as Cx601, a stem cell therapy that treats complex perianal fistulas, one of the most restricting complications of Crohn’s disease. Alofisel was developed by Belgian biotech company TiGenix, and is licensed to the Japanese pharma Takeda. It is the first stem cell therapy created through donor stem … Read more